ERBB2 and breast cancer: Of the 471 paired cases, the following were excluded: HER2-positive breast cancer (n = 4), ER-positive breast cancer (≥ 10%) (n = 12), cases missing pathology report numbers in LIS (n = 13) and one patient deceased before surgery (n = 1).